Publications

2017

  1. Novick D. (2017) International Journal of Chromatography and Separation Techniques. 10, IJCST-110.  Abstract
  2. Novick D. & Dinarello C. A. (2017) Journal of Allergy and Clinical Immunology. 140, 1, p. 316-316  Abstract

2015

  1. Novick D., Kim S. & Dinarello C. A. (2015) Encyclopedia of Inflammatory Diseases. Parnham M.(eds.). p. 1-7  Abstract

2014

  1. Novick D., Barak S., Ilan N. & Vlodavsky I. (2014) PLoS One. 9, 1,  Abstract

2013

  1. Novick D., Kim S., Kaplanski G. & Dinarello C. A. (2013) Seminars in Immunology. 25, 6, p. 439-448  Abstract
  2. Novick D. (2013) Frontiers in Immunology. 4, 289,  Abstract
  3. Finkelshtein D., Werman A., Novick D., Barak S. & Rubinstein M. (2013) Proceedings of the National Academy of Sciences of the United States of America. 110, 18, p. 7306-7311  Abstract

2011

  1. Novick D. & Rubinstein M. (2011) Cytokine Protocols. p. 195-214 (Methods in Molecular Biology).  Abstract

2010

  1. Novick D. (2010) Nat Immunol.  Abstract
  2. Novick D., Elbirt D., Miller G., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2010) Journal of Autoimmunity. 34, 2, p. 121-126  Abstract

2009

  1. Novick D., Elbirt D., Dinarello C. A., Rubinstein M. & Sthoeger Z. M. (2009) Journal of Clinical Immunology. 29, 1, p. 38-45  Abstract
  2. Favilli F., Anzilotti C., Martinelli L. et al. (2009) Contemporary Challenges In Autoimmunity. 1173, p. 301-309  Abstract
    [All authors]

2008

  1. Werman A., Korba B. E., Alkahe B., Finkelshtein D., Bujanover S., Novick D., Vinocour E. & Rubinstein M. (2008) Cytokine. 43, 3, p. 249-249  Abstract
  2. Leach S. T., Messina I., Lemberg D. A., Novick D., Rubenstein M. & Day A. S. (2008) Inflammatory Bowel Diseases. 14, 1, p. 68-74  Abstract

2007

  1. Thompson S. R., Novick D., Stock C. J. et al. (2007) ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY. 27, 12, p. 2743-2749  Abstract
    [All authors]
  2. Novick D. & Rubinstein M. (2007) Cytokine & Growth Factor Reviews. 18, 6-May, p. 525-533  Abstract
  3. Naftali T., Novick D., Gabay G., Rubinstein M. & Novis B. (2007) Israel Medical Association Journal. 9, 7, p. 504-508  Abstract
  4. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Cytokine. 39, 1, p. 17-17  Abstract
  5. Thompson S. R., Novick D., Stock C., Rubinstein M., Woo P., Humphries S. E. & Sanders J. (2007) Atherosclerosis Supplements. 8, 1, p. 52-52  Abstract
  6. Hurgin V., Novick D., Werman A., Dinarello C. A. & Rubinstein M. (2007) Proceedings of the National Academy of Sciences of the United States of America. 104, 12, p. 5044-5049  Abstract

2006

  1. Novick D., Rubinstein M., Azam T., Rabinkov A., Dinarello C. & Kim S. (2006) Proceedings of the National Academy of Sciences of the United States of America. 103, 9, p. 3316-3321  Abstract

2005

  1. Neumayr G., Ludwiczek O., Hoertnagl H., Pfister R., Mitterbauer G., Moschen A., Novick D., Rubinstein M. & Tilg H. (2005) International Journal of Sports Medicine. 26, 10, p. 836-840  Abstract
  2. Mazodier K., Marin V., Novick D. et al. (2005) Blood. 106, 10, p. 3483-3489  Abstract
    [All authors]
  3. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease
    Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M. & Tilg H. (2005) European Cytokine Network. 16, 1, p. 27-33  Abstract

2004

  1. Gutman G., Har-Toov J., Many A., Lessing J., Novick D., Rubinstein M. & Jaffa A. (2004) American Journal of Obstetrics and Gynecology. 191, 6, p. S152-S152  Abstract
  2. Kawashima M., Novick D., Rubinstein M. & Miossec P. (2004) Arthritis and Rheumatology. 50, 6, p. 1800-1805  Abstract

2003

  1. Identification of a critical Ig-like domain in IL-18 receptor alpha and characterization of a functional IL-18 receptor complex
    Azam T., Novick D., Bufler P., Yoon D., Rubinstein M., Dinarello C. & Kim S. (2003) Journal of Immunology. 171, 12, p. 6574-6580  Abstract
  2. Interleukin-18, interleukin-18 binding protein and impaired production of interferon-gamma in chronic renal failure
    Lonnemann G., Novick D., Rubinstein M. & Dinarello C. (2003) Clinical Nephrology. 60, 5, p. 327-334  Abstract
  3. Feezor R., Oberholzer C., Baker H. et al. (2003) Infection and Immunity. 71, 10, p. 5803-5813  Abstract
    [All authors]
  4. Gangemi S., Basile G., Merendino R. et al. (2003) Experimental Gerontology. 38, 6, p. 669-672  Abstract
    [All authors]
  5. Pignatti P., Ciapponi L., Galle P. et al. (2003) Clinical and Experimental Immunology. 131, 2, p. 355-363  Abstract
    [All authors]
  6. Nolsoe R., Pociot F., Novick D., Rubinstein M., Kim S., Dinarello C. & Mandrup-Poulsen T. (2003) Immunology Of Diabetes Ii: Pathogenesis From Mouse To Man. 1005, p. 332-339  Abstract
  7. Lonnemann G., Novick D., Rubinstein M., Passlick-Deetjen J., Lang D. & Dinarello C. (2003) Blood Purification. 21, 3, p. 225-231  Abstract
  8. Dinarello C., Novick D., Rubinstein M. & Lonnemann G. (2003) Blood Purification. 21, 3, p. 258-270  Abstract
  9. Stuyt R., Kim S., Reznikov L. et al. (2003) Cytokine. 21, 2, p. 65-73  Abstract
    [All authors]

2002

  1. Hurgin V., Novick D. & Rubinstein M. (2002) Proceedings of the National Academy of Sciences of the United States of America. 99, 26, p. 16957-16962  Abstract
  2. Ludwiczek O., Kaser A., Novick D., Dinarello C., Rubinstein M., Vogel W. & Tilg H. (2002) Journal of Clinical Immunology. 22, 6, p. 331-337  Abstract
  3. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury
    Yatsiv I., Morganti-Kossmann M., Perez D. et al. (2002) Journal of Cerebral Blood Flow and Metabolism. 22, 8, p. 971-978  Abstract
    [All authors]
  4. Kaser A., Novick D., Rubinstein M. et al. (2002) Clinical and Experimental Immunology. 129, 2, p. 332-338  Abstract
    [All authors]
  5. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components
    Ariel A., Novick D., Rubinstein M., Dinarello C., Lider O. & Hershkoviz R. (2002) Journal of Leukocyte Biology. 72, 1, p. 192-198  Abstract
  6. IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease
    Corbaz A., ten Hove H. T., Herren S. et al. (2002) Journal of Immunology. 168, 7, p. 3608-3616  Abstract
    [All authors]
  7. Kim S., Azam T., Novick D., Yoon D., Reznikov L., Bufler P., Rubinstein M. & Dinarello C. (2002) Journal of Biological Chemistry. 277, 13, p. 10998-11003  Abstract

2001

  1. Zecchina G., Novick D., Rubinstein M., Barak V., Dinarello C. & Nagler A. (2001) Journal Of Hematotherapy & Stem Cell Research. 10, 6, p. 769-776  Abstract
  2. Stuyt R., Netea M., Kim S., Novick D., Rubinstein M., Kullberg B., Van der Meer d. M. J. & Dinarello C. (2001) Infection and Immunity. 69, 8, p. 5025-5030  Abstract
  3. Novick D., Schwartsburd B., Pinkus R. et al. (2001) Cytokine. 14, 6, p. 334-342  Abstract
    [All authors]
  4. Kim S., Azam T., Yoon D., Reznikov L., Novick D., Rubinstein M. & Dinarello C. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 6, p. 3304-3309  Abstract

2000

  1. Novick D., Nabioullin R., Ragsdale W. et al. (2000) Journal of Interferon and Cytokine Research. 20, 11, p. 971-982  Abstract
    [All authors]
  2. Liu B., Novick D., Kim S. & Rubinstein M. (2000) Cytokine. 12, 10, p. 1519-1525  Abstract
  3. Banks R., Forbes M., Patel P. et al. (2000) Cytokine. 12, 4, p. 388-396  Abstract
    [All authors]
  4. Reznikov L., Kim S., Westcott J., Frishman J., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 5, p. 2174-2179  Abstract
  5. Kim S., Eisenstein M., Reznikov L., Fantuzzi G., Novick D., Rubinstein M. & Dinarello C. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 3, p. 1190-1195  Abstract
  6. Haicheur N., Escudier B., Dorval T. et al. (2000) Clinical and Experimental Immunology. 119, 1, p. 28-37  Abstract
    [All authors]
  7. Vidal-Vanaclocha F., Fantuzzi G., Mendoza L. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 2, p. 734-739  Abstract
    [All authors]

1999

  1. Jones S., Novick D., Horiuchi S., Yamamoto N., Szalai A. & Fuller G. (1999) Journal of Experimental Medicine. 189, 3, p. 599-604  Abstract
  2. Novick D., Kim S., Fantuzzi G., Reznikov L., Dinarello C. & Rubinstein M. (1999) Immunity. 10, 1, p. 127-136  Abstract

1998

  1. Jones S., Horiuchi S., Novick D., Yamamoto N. & Fuller G. (1998) European Journal of Immunology. 28, 11, p. 3514-3522  Abstract
  2. Shapiro L., Puren A., Barton H., Novick D., Peskind R., Shenkar R., Gu Y., Su M. & Dinarello C. (1998) Proceedings of the National Academy of Sciences of the United States of America. 95, 21, p. 12550-12555  Abstract
  3. Overview of interleukin-18: more than an interferon-gamma inducing factor
    Dinarello C., Novick D., Puren A. et al. (1998) Journal of Leukocyte Biology. 63, 6, p. 658-664  Abstract
    [All authors]

1997

  1. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies
    Toren A., Barak V., Novick D. & Nagler A. (1997) Cytokines Cellular & Molecular Therapy. 3, 3, p. 153-158  Abstract
  2. Kim S., Cohen B., Novick D. & Rubinstein M. (1997) Gene. 196, 2-Jan, p. 279-286  Abstract
  3. Mechanism(s) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis
    Ambrus J., Chadha S., Novick D., Rubinstein M., Gopalakrishnan B., Bernstein Z., Priore R. & Chadha K. (1997) Research Communications in Molecular Pathology and Pharmacology. 96, 3, p. 255-265  Abstract
  4. Interleukin-6 and interleukin-6 receptor secretion by chronic lymphatic leukaemia and normal B lymphocytes: Effect of PMA and PWM
    Drucker I., Klajman A., Revel M., Manor Y., BenEfraim S. & Novick D. (1997) Mediators of Inflammation. 6, 2, p. 147-153  Abstract

1996

  1. Cohen B., Novick D. & Rubinstein M. (1996) Science. 274, 5290, p. 1185-1188  Abstract
  2. Soluble IL-6 receptors (sIL-6R) in hematological patients receiving immunotherapy with IL-2/IFN-alpha or donor lymphocytes following bone marrow transplantation
    Toren A., Novick D., Ackerstein A., Or R., Slavin S. & Nagler A. (1996) Bone Marrow Transplantation. 18, 4, p. 721-724  Abstract
  3. Immunohistochemical studies of proinflammatory cytokines and their receptors in hair follicles of normal human skin
    Ahmed A., Nordlind K., Schultzberg M., Brakenhoff J., Bristulf J., Novick D., Svenson S., Azizi M. & Liden S. (1996) Acta Dermato-Venereologica. 76, 5, p. 348-352  Abstract
  4. Wasik M., Sackstein R., Novick D., Butmarc J., Zhang Q., Vonderheid E. & Kadin M. (1996) Human Pathology. 27, 7, p. 738-744  Abstract
  5. Toren A., Novick D., Or R., Ackerstein A., Slavin S. & Nagler A. (1996) Transplantation. 62, 1, p. 138-142  Abstract

1995

  1. LIGAND-INDUCED ASSOCIATION OF THE TYPE-I INTERFERON RECEPTOR COMPONENTS
    Cohen B., Novick D., Barak S. & Rubinstein M. (1995) Molecular and Cellular Biology. 15, 8, p. 4208-4214  Abstract
  2. OPSJON S., Novick D., WATHEN N., COPE A., Wallach D. & ADERKA D. (1995) Journal of Reproductive Immunology. 29, 2, p. 119-134  Abstract
  3. SOLUBLE AND MEMBRANE-ANCHORED FORMS OF THE HUMAN IFN-ALPHA/BETA RECEPTOR
    Novick D., Cohen B., Tal N. & Rubinstein M. (1995) Journal of Leukocyte Biology. 57, 5, p. 712-718  Abstract

1994

  1. ISOLATION AND CHARACTERIZATION OF A SOLUBLE FORM OF THE LDL RECEPTOR, AN INTERFERON-INDUCED ANTIVIRAL PROTEIN
    FISCHER D., Novick D., Cohen B. & Rubinstein M. (1994) Proceedings Of The Society For Experimental Biology And Medicine. 206, 3, p. 228-232  Abstract
  2. Novick D., Cohen B. & Rubinstein M. (1994) Cell. 77, 3, p. 391-400  Abstract
  3. DEBENEDETTI F., MASSA M., PIGNATTI P., ALBANI S., Novick D. & MARTINI A. (1994) Journal of Clinical Investigation. 93, 5, p. 2114-2119  Abstract

1993

  1. FISCHER D., Tal N., Novick D., Barak S. & Rubinstein M. (1993) Science. 262, 5131, p. 250-253  Abstract
  2. INTERLEUKIN-6 INHIBITS THE PROLIFERATION OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS THAT IS INDUCED BY TUMOR-NECROSIS-FACTOR-ALPHA OR FACTOR-BETA
    ADERKA D., MAOR Y., Novick D., ENGELMANN H., KAHN Y., LEVO Y., Wallach D. & Revel M. (1993) Blood. 81, 8, p. 2076-2084  Abstract

1992

  1. EDELBAUM O., STEIN D., HOLLAND N., GAFNI Y., Livneh O., Novick D., Rubinstein M. & Sela I. (1992) Journal of Interferon Research. 12, 6, p. 449-453  Abstract
  2. Novick D., Cohen B. & Rubinstein M. (1992) FEBS Letters. 314, 3, p. 445-448  Abstract

1991

  1. EDELBAUM O., SHER N., Rubinstein M., Novick D., Tal N., MOYER M., WARD E., RYALS J. & Sela I. (1991) Plant Molecular Biology. 17, 1, p. 171-173  Abstract
  2. Novick D., ENGELMANN H., Revel M., Leitner O. & Rubinstein M. (1991) Hybridoma. 10, 1, p. 137-146  Abstract
  3. PRODUCTION, DOWNSTREAM PROCESSING AND CHARACTERIZATION OF PROTEINS FROM RECOMBINANT ANIMAL-CELLS - THE CASE OF HUMAN INTERFERON-BETA
    Rubinstein M., Revel M., Novick D. et al. (1991) Biologicals From Recombinant Microorganisms And Animal Cells: Production And Recovery. p. 479-486  Abstract
    [All authors]

1990

  1. Novick D., ENGELMANN H., Wallach D., Leitner O., Revel M. & Rubinstein M. (1990) Journal of Chromatography. 510, p. 331-337  Abstract
  2. EDELBAUM O., ILAN N., GRAFI G., SHER N., STRAM Y., Novick D., Tal N., Sela I. & Rubinstein M. (1990) Proceedings of the National Academy of Sciences of the United States of America. 87, 2, p. 588-592  Abstract
  3. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors
    ENGELMANN H., Novick D. & Wallach D. (1990) Journal of Biological Chemistry. 265, 3, p. 1531-1536  Abstract
  4. EFFECTS OF RECOMBINANT HUMAN IL-6 ON BREAST-CANCER CELLS
    Revel M., CHEN L., Novick D. & SHULMAN L. (1990) Molecular And Cellular Biology Of Cytokines. 10, p. 509-515  Abstract
  5. SOLUBLE CYTOKINE-RECEPTORS ARE PRESENT IN NORMAL HUMAN URINE
    Novick D., ENGELMANN H., Wallach D. & Rubinstein M. (1990) Physiological And Pathological Effects Of Cytokines. 10, p. 413-421  Abstract
  6. SOLUBLE FORMS OF THE TNF RECEPTORS, PURIFIED FROM HUMAN URINE, INHIBIT TNF EFFECTS - ANTIBODIES AGAINST THE SOLUBLE RECEPTORS INDUCE TNF-LIKE EFFECTS
    ENGELMANN H., ADERKA D., HOLTMANN H. et al. (1990) Molecular And Cellular Biology Of Cytokines. 10, p. 299-308  Abstract
    [All authors]

1989

  1. Novick D., ENGELMANN H., Wallach D. & Rubinstein M. (1989) Journal of Experimental Medicine. 170, 4, p. 1409-1414  Abstract
  2. Novick D., Eshhar Z., Revel M. & MORY Y. (1989) Hybridoma. 8, 5, p. 561-567  Abstract
  3. BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2 IL-6 (ESCHERICHIA-COLI)
    Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Annals of the New York Academy of Sciences. 557, p. 144-156  Abstract
  4. Novick D., FISCHER D., REITER Z., Eshhar Z. & Rubinstein M. (1989) Journal of Interferon Research. 9, 3, p. 315-328  Abstract
  5. BIOLOGICAL-ACTIVITIES OF RECOMBINANT HUMAN IFN-BETA-2/IL-6 (ESCHERICHIA-COLI)
    Revel M., ZILBERSTEIN A., CHEN L., GOTHELF Y., BARASH I., Novick D., Rubinstein M. & MICHALEVICZ R. (1989) Regulation Of The Acute Phase And Immune Responses : Interleukin-6. 557, p. 144-156  Abstract

1988

  1. CHEN L., Novick D., Rubinstein M. & Revel M. (1988) FEBS Letters. 239, 2, p. 299-304  Abstract
  2. FISCHER D., Novick D., ORCHANSKY P. & Rubinstein M. (1988) Journal of Biological Chemistry. 263, 6, p. 2632-2637  Abstract

1987

  1. ROWE D., GRIFFITHS M., STEWART J., Novick D., BEVERLEY P. & ISENBERG D. (1987) Annals of the Rheumatic Diseases. 46, 8, p. 580-586  Abstract
  2. Rubinstein M., Novick D. & FISCHER D. (1987) Immunological Reviews. 97, p. 29-50  Abstract
  3. THE HUMAN INTERFERON-GAMMA RECEPTOR - PURIFICATION, CHARACTERIZATION, AND PREPARATION OF ANTIBODIES
    Novick D., ORCHANSKY P., Revel M. & Rubinstein M. (1987) Journal of Biological Chemistry. 262, 18, p. 8483-8487  Abstract

1986

  1. MORY Y., BENBARAK J., SEGEV D. et al. (1986) Dna-A Journal Of Molecular & Cellular Biology. 5, 3, p. 181-193  Abstract
    [All authors]
  2. LOCALIZATION OF INTERFERONS AND INTERLEUKIN 2 IN POLYMYOSITIS AND MUSCULAR-DYSTROPHY
    ISENBERG D., ROWE D., SHEARER M., Novick D. & BEVERLEY P. (1986) Clinical and Experimental Immunology. 63, 2, p. 450-458  Abstract

1985

  1. ADERKA D., Novick D., HAHN T., FISCHER D. & Wallach D. (1985) Cellular Immunology. 92, 2, p. 218-225  Abstract

1984

  1. ORCHANSKY P., Novick D., FISCHER D. & Rubinstein M. (1984) Journal of Interferon Research. 4, 2, p. 275-282  Abstract
  2. CHERNAJOVSKY Y., MORY Y., CHEN L., MARKS Z., Novick D., Rubinstein M. & Revel M. (1984) Dna-A Journal Of Molecular & Cellular Biology. 3, 4, p. 297-308  Abstract

1983

  1. Novick D., Eshhar Z., FISCHER D., FRIEDLANDER J. & Rubinstein M. (1983) EMBO Journal. 2, 9, p. 1527-1530  Abstract
  2. Novick D., Eshhar Z., GIGI O., MARKS Z., Revel M. & Rubinstein M. (1983) Journal of General Virology. 64, APR, p. 905-910  Abstract

1982

  1. MONOCLONAL-ANTIBODIES TO HUMAN ALPHA-INTERFERON AND THEIR USE FOR AFFINITY-CHROMATOGRAPHY
    Novick D., Eshhar Z. & Rubinstein M. (1982) Journal of Immunology. 129, 5, p. 2244-2247  Abstract

1980

  1. Fuchs S., BARTFELD D., Eshhar Z., FEINGOLD C., MOCHLYROSEN D., Novick D., Schwartz M. & TARRABHAZDAI R. (1980) Journal Of Neurology Neurosurgery And Psychiatry. 43, 7, p. 634-643  Abstract

1978